查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1400997

按技術、治療領域、最終用戶、國家和地區分類的人類絨毛膜促性腺激素 (hCG) 市場與 COVID-19 影響分析 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Human Chorionic Gonadotropin (hCG) Market with COVID-19 Impact Analysis by Technology, Therapeutic Area, End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年人類絨毛膜促性腺激素 (hCG) 市場規模為 7,1,087 萬美元，2023 年至 2030 年複合CAGR為 6.48%。

人類絨毛膜促性腺激素 (hCG) 市場-市場動態

不孕症和性腺功能減退症的盛行率不斷上升，生活方式的改變以及對不孕症治療的認知不斷提高，以推動市場需求

不孕症和性腺功能減退症盛行率的上升、生活方式的改變以及不孕症治療知識的提高都有助於人類絨毛膜促性腺激素 (HCG) 行業的擴張。例如，性腺功能減退症的定義是血清睪固酮激素濃度低，隨後出現一系列臨床特徵，如晨勃不良、勃起功能障礙、記憶力減退、性慾低下、身體健康和體力下降、注意力不集中和憂鬱。根據 BMC Endocrine Disorders 2021 年 7 月發布的研究，到 2021 年，勃起功能障礙將影響全球 72.2% 的成年人。

人類絨毛膜促性腺激素 (hCG) 市場 - 關鍵見解

根據我們的研究分析師分享的分析，全球人類絨毛膜促性腺激素 (hCG) 市場預計在預測期內（2023-2030 年）每年將以 6.48% 左右的CAGR成長

由於不孕症和性腺功能減退症盛行率的增加、生活方式的改變以及對不孕症治療認知的提高，預計人類絨毛膜促性腺激素 (hCG) 行業將以顯著的速度成長

基於技術細分，預計天然來源提取將在 2022 年顯示最大的市場佔有率

基於治療領域細分，2022年女性不孕症治療技術領先

根據最終用戶細分，生育診所是 2022 年的領先技術

按地區分類，北美是 2022 年的主要收入來源

人類絨毛膜促性腺激素 (hCG) 市場-細分分析：

全球人類絨毛膜促性腺激素 (hCG) 市場根據技術、治療領域、最終用戶和地區進行細分。

市場根據產品技術分為兩類：重組技術和天然來源提取。天然來源提取領域在全球市場中佔據主導地位，並且在預測期內可能會繼續如此。 hCG 領域的主要競爭對手對天然來源的促性腺激素有很高的需求，這是過去幾年市場的重要發展，並為該領域的收入做出了重大貢獻。

市場依治療領域分為：男性性腺功能減退症、女性不孕症治療、少精子症治療等。不孕症被描述為夫婦無法懷孕或女性無法維持妊娠至足月。由於人類絨毛膜促性腺激素 (HCG) 激素對懷孕期間胚胎發育非常重要，因此其在不孕症治療中的應用在男性和女性中都受到歡迎。女性不孕症可由多種因素引起。據世界衛生組織稱，輸卵管異常，如子宮疾病、輸卵管阻塞、卵泡問題、多囊性卵巢症候群（PCOS）以及各種內分泌系統疾病是主要原因。

人類絨毛膜促性腺激素 (hCG) 市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。在預測期內，北美預計將經歷可觀的市場成長。這一成長可能與該地區完善的醫療基礎設施、有利的報銷規定以及不斷增加的不孕負擔有關。

人類絨毛膜促性腺激素 (hCG) 市場-競爭格局：

公司透過多種管道銷售產品，包括企業網站、電子商務網站、零售商、分銷​​商和最終消費者。企業用來擴大影響力和擴大市場佔有率的一些主要技術包括新產品發布、分銷網路開發、研發支出以及併購。例如，2022 年 6 月，Inception Fertility 推出了 HavenCryo，擴展了其生態系統，這是一種長期生物組織和冷凍保存解決方案，為生育專業人士和患者提供了獨一無二的體驗。

最近的發展：

2022 年 6 月，隨著 HavenCryo 的推出，這是一種長期生殖組織和冷凍保存解決方案，為生育從業者和患者提供了獨特的體驗，Inception Fertility 擴展了其生態系統。

目錄

第 1 章：人類絨毛膜促性腺激素 (hCG) 市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按技術分類的人類絨毛膜促性腺激素 (hCG) 市場片段
    • 按治療領域分類的人類絨毛膜促性腺激素 (hCG) 市場片段
    • 最終用戶的人類絨毛膜促性腺激素 (hCG) 市場片段
    • 按國家/地區分類的人類絨毛膜促性腺激素 (hCG) 市場片段
    • 按地區分類的人類絨毛膜促性腺激素 (hCG) 市場片段
  • 競爭洞察

第 3 章：人類絨毛膜促性腺激素 (hCG) 主要市場趨勢

  • 人類絨毛膜促性腺激素 (hCG) 市場促進因素
    • 市場促進因素的影響分析
  • 人類絨毛膜促性腺激素 (hCG) 市場限制
    • 市場限制影響分析
  • 人類絨毛膜促性腺激素 (hCG) 市場機會
  • 人類絨毛膜促性腺激素（hCG）市場未來趨勢

第 4 章：人類絨毛膜促性腺激素 (hCG) 產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：人類絨毛膜促性腺激素 (hCG) 市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：人類絨毛膜促性腺激素 (hCG) 市場格局

  • 2022 年人類絨毛膜促性腺激素 (hCG) 市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：人類絨毛膜促性腺激素 (hCG) 市場 - 依技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 重組技術
    • 天然來源萃取

第 8 章：人類絨毛膜促性腺激素 (hCG) 市場 - 依治療領域

  • 概述
    • 按治療領域分類的細分市場佔有率分析
    • 男性性腺功能減退症
    • 女性不孕症治療
    • 少精症治療
    • 其他

第 9 章：人類絨毛膜促性腺激素 (hCG) 市場 - 依最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 研究機構
    • 生育診所
    • 其他

第 10 章：人類絨毛膜促性腺激素 (hCG) 市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美人類絨毛膜促性腺激素 (hCG) 主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按技術）
    • 北美市場規模與預測（按治療領域）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲人類絨毛膜促性腺激素 (hCG) 主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模與預測（按治療領域）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區人類絨毛膜促性腺激素 (hCG) 主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按技術）
    • 按治療領域分類的亞太市場規模和預測
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲人類絨毛膜促性腺激素 (hCG) 主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模與預測（按治療領域）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲人絨毛膜促性腺激素 (hCG) 主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按治療領域）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 人類絨毛膜促性腺激素 (hCG) 產業

  • 競爭儀表板
  • 公司簡介
    • Zydus Cadila
    • Torrent Pharmaceuticals
    • Sun Pharmaceutical Industries Ltd.
    • Sigma-Aldrich (now part of MilliporeSigma)
    • Organon
    • Novartis
    • Merck
    • Mankind Pharma
    • Lupin Pharmaceuticals
    • Liqvor Pharmaceuticals
    • IBSA Pharma
    • Glenmark Pharmaceuticals
    • Ferring Pharmaceuticals
    • Bharat Serums and Vaccines Ltd.
    • Anhui Anke Biotechnology (Anhui Anke Biotechnology Co., Ltd.)

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1961

REPORT HIGHLIGHT

Human Chorionic Gonadotropin (hCG) Market size was valued at USD 710.87 Million in 2022, expanding at a CAGR of 6.48% from 2023 to 2030.

Human Chorionic Gonadotropin (hCG) is a hormone generated by the placenta during pregnancy. It aids pregnancy by activating the corpus luteum in the ovaries to generate progesterone, which maintains the uterine lining and helps the growing fetus. hCG is also the hormone discovered in pregnancy tests since its levels grow considerably early in pregnancy. In addition to its role in reproduction, hCG has therapeutic applications, including as in fertility therapies and as a marker for various medical disorders, including several cancer technologies.

Human Chorionic Gonadotropin (hCG) Market- Market Dynamics

Increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment to propel market demand

The rising prevalence of infertility and hypogonadism, changing lifestyles, and improved knowledge about infertility therapy are all contributing to the expansion of the human chorionic gonadotropin (HCG) industry. Hypogonadism, for example, is defined by low serum the hormone testosterone concentration, which is followed by an array of clinical features such as poor morning erections, ED, memory loss, low libido, physical decline in health and power, difficulty concentrating, and depression. According to research published in July 2021 by BMC Endocrine Disorders, erectile dysfunction would affect 72.2% of adults worldwide in 2021.

Human Chorionic Gonadotropin (hCG) Market- Key Insights

As per the analysis shared by our research analyst, the global Human Chorionic Gonadotropin (hCG) market is estimated to grow annually at a CAGR of around 6.48% over the forecast period (2023-2030)

The Human Chorionic Gonadotropin (hCG) industry is projected to grow at a significant rate due to the increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment

Based on Technology segmentation, natural source extraction was predicted to show maximum market share in the year 2022

Based on Therapeutic Area segmentation, Female Infertility Treatment was the leading Technology in 2022

Based on end user segmentation, Fertility Clinics was the leading Technology in 2022

On the basis of region, North America was the leading revenue generator in 2022

Human Chorionic Gonadotropin (hCG) Market- Segmentation Analysis:

The Global Human Chorionic Gonadotropin (hCG) Market is segmented on the basis of Technology, Therapeutic Area, End User, and Region.

The market is divided into categories based on product Technology: Recombinant Technology and Natural Source Extraction. The natural source extraction segment dominated the worldwide market and is likely to continue to do so during the forecast period. The leading competitors in the hCG sector have a high demand for gonadotropins derived from natural sources, which has been an important development in the market over the past few years and has contributed significantly to the income earned by this segment.

The market is divided into categories based on Therapeutic Area: Male Hypogonadism, Female Infertility Treatment, Oligospermia Treatment, and Others. Infertility is described as the couple's inability to become pregnant or the woman's inability to sustain a pregnancy to term. Because the human chorionic gonadotropin (HCG) hormone is important following embryo development during pregnancy, its usage in infertility therapy has gained popularity in both men and women. Female infertility can be caused by a variety of factors. Tubal abnormalities such as a uterine illness, blocked fallopian tube, follicular problems, polycystic ovarian syndrome (PCOS), various and endocrine system disorders are among the leading causes, according to the World Health Organization.

Human Chorionic Gonadotropin (hCG) Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Over the projection period, North America is expected to experience considerable market growth. The rise can be linked to the region's well-established healthcare infrastructure, advantageous reimbursement regulations, and the rising burden of infertility.

Human Chorionic Gonadotropin (hCG) Market- Competitive Landscape:

Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in June 2022, Inception Fertility extended its ecosystem with the introduction of HavenCryo, a long-term biological tissue and cryopreservation preservation solution that provides fertility professionals and patients with a one-of-a-kind experience.

Recent Developments:

In June 2022, with the introduction of HavenCryo, a long-term reproductive tissue and cryopreservation storage solution that provides a distinctive experience for fertility practitioners and patients, Inception Fertility extended its ecosystem.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET KEY PLAYERS

  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Sigma-Aldrich (now part of MilliporeSigma)
  • Organon
  • Novartis
  • Merck
  • Mankind Pharma
  • Lupin Pharmaceuticals
  • Liqvor Pharmaceuticals
  • IBSA Pharma
  • Glenmark Pharmaceuticals
  • Ferring Pharmaceuticals
  • Bharat Serums and Vaccines Ltd.
  • Anhui Anke Biotechnology (Anhui Anke Biotechnology Co., Ltd.)

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY TECHNOLOGY

  • Recombinant Technology
  • Natural Source Extraction

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY THERAPEUTIC AREA

  • Male Hypogonadism
  • Female Infertility Treatment
  • Oligospermia Treatment
  • Others

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY END USER

  • Research Institutes
  • Fertility Clinics
  • Others

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Chorionic Gonadotropin (hCG) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Chorionic Gonadotropin (hCG) Market Snippet by Technology
    • 2.1.2. Human Chorionic Gonadotropin (hCG) Market Snippet by Therapeutic Area
    • 2.1.3. Human Chorionic Gonadotropin (hCG) Market Snippet by End User
    • 2.1.4. Human Chorionic Gonadotropin (hCG) Market Snippet by Country
    • 2.1.5. Human Chorionic Gonadotropin (hCG) Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Chorionic Gonadotropin (hCG) Key Market Trends

  • 3.1. Human Chorionic Gonadotropin (hCG) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Chorionic Gonadotropin (hCG) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Chorionic Gonadotropin (hCG) Market Opportunities
  • 3.4. Human Chorionic Gonadotropin (hCG) Market Future Trends

4. Human Chorionic Gonadotropin (hCG) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Chorionic Gonadotropin (hCG) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Human Chorionic Gonadotropin (hCG) Market Landscape

  • 6.1. Human Chorionic Gonadotropin (hCG) Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Chorionic Gonadotropin (hCG) Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 7.1.2. Recombinant Technology
    • 7.1.3. Natural Source Extraction

8. Human Chorionic Gonadotropin (hCG) Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2022 & 2030 (%)
    • 8.1.2. Male Hypogonadism
    • 8.1.3. Female Infertility Treatment
    • 8.1.4. Oligospermia Treatment
    • 8.1.5. Others

9. Human Chorionic Gonadotropin (hCG) Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Research Institutes
    • 9.1.3. Fertility Clinics
    • 9.1.4. Others

10. Human Chorionic Gonadotropin (hCG) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Human Chorionic Gonadotropin (hCG) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Zydus Cadila
    • 11.2.2. Torrent Pharmaceuticals
    • 11.2.3. Sun Pharmaceutical Industries Ltd.
    • 11.2.4. Sigma-Aldrich (now part of MilliporeSigma)
    • 11.2.5. Organon
    • 11.2.6. Novartis
    • 11.2.7. Merck
    • 11.2.8. Mankind Pharma
    • 11.2.9. Lupin Pharmaceuticals
    • 11.2.10. Liqvor Pharmaceuticals
    • 11.2.11. IBSA Pharma
    • 11.2.12. Glenmark Pharmaceuticals
    • 11.2.13. Ferring Pharmaceuticals
    • 11.2.14. Bharat Serums and Vaccines Ltd.
    • 11.2.15. Anhui Anke Biotechnology (Anhui Anke Biotechnology Co., Ltd.)

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Human Chorionic Gonadotropin (hCG) Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by Technology 2018-2030 (USD Million)
  • TABLE Human Chorionic Gonadotropin (hCG) Market: Therapeutic Area Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area 2018-2030 (USD Million)
  • TABLE Human Chorionic Gonadotropin (hCG) Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by End User 2018-2030 (USD Million)
  • TABLE Human Chorionic Gonadotropin (hCG) Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by Region 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)